This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference

NATICK, Mass., Nov. 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 25 th Annual Piper Jaffray Healthcare Conference on December 3 in New York.

Mike Mahoney, president and chief executive officer, and Dan Brennan, senior vice president and corporate controller, will participate in a 30-minute question and answer session regarding the company on Tuesday, December 3, at approximately 8:30 a.m. ET.

A live webcast of the question and answer session will be available to interested parties via the Boston Scientific website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

This webcast is being hosted by Piper Jaffray.  A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACT:   Denise Kaigler508-650-8330 (office)Global Corporate CommunicationsBoston Scientific Corporation media@bsci.com

Michael Campbell508-650-8023 (office)Investor RelationsBoston Scientific Corporation investor_relations@bsci.com

SOURCE Boston Scientific Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,033.60 -36.80 -0.20%
S&P 500 2,104.69 -9.80 -0.46%
NASDAQ 4,969.0050 -47.9240 -0.96%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs